nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—Methyldopa—DDC—Parkinson's disease	0.0176	0.315	CrCbGaD
Aminosalicylic Acid—Droxidopa—DDC—Parkinson's disease	0.011	0.196	CrCbGaD
Aminosalicylic Acid—L-DOPA—DDC—Parkinson's disease	0.00924	0.165	CrCbGaD
Aminosalicylic Acid—CHUK—cardiovascular system—Parkinson's disease	0.00872	0.093	CbGeAlD
Aminosalicylic Acid—Methyldopa—COMT—Parkinson's disease	0.00786	0.14	CrCbGaD
Aminosalicylic Acid—CHUK—head—Parkinson's disease	0.0059	0.063	CbGeAlD
Aminosalicylic Acid—CHUK—cerebellum—Parkinson's disease	0.00527	0.0562	CbGeAlD
Aminosalicylic Acid—MPO—forebrain—Parkinson's disease	0.00491	0.0524	CbGeAlD
Aminosalicylic Acid—ALOX5—cardiovascular system—Parkinson's disease	0.00491	0.0524	CbGeAlD
Aminosalicylic Acid—CHUK—brain—Parkinson's disease	0.00428	0.0456	CbGeAlD
Aminosalicylic Acid—MPO—cardiovascular system—Parkinson's disease	0.00416	0.0443	CbGeAlD
Aminosalicylic Acid—ALOX5—head—Parkinson's disease	0.00333	0.0355	CbGeAlD
Aminosalicylic Acid—MPO—spinal cord—Parkinson's disease	0.00317	0.0338	CbGeAlD
Aminosalicylic Acid—ALOX5—nervous system—Parkinson's disease	0.00315	0.0336	CbGeAlD
Aminosalicylic Acid—ALOX5—central nervous system—Parkinson's disease	0.00304	0.0324	CbGeAlD
Aminosalicylic Acid—ALOX5—cerebellum—Parkinson's disease	0.00297	0.0317	CbGeAlD
Aminosalicylic Acid—L-DOPA—DRD3—Parkinson's disease	0.00288	0.0516	CrCbGaD
Aminosalicylic Acid—L-DOPA—DRD1—Parkinson's disease	0.00283	0.0506	CrCbGaD
Aminosalicylic Acid—MPO—head—Parkinson's disease	0.00281	0.03	CbGeAlD
Aminosalicylic Acid—MPO—nervous system—Parkinson's disease	0.00267	0.0285	CbGeAlD
Aminosalicylic Acid—MPO—central nervous system—Parkinson's disease	0.00257	0.0274	CbGeAlD
Aminosalicylic Acid—PTGS2—embryo—Parkinson's disease	0.00252	0.0269	CbGeAlD
Aminosalicylic Acid—ALOX5—brain—Parkinson's disease	0.00241	0.0257	CbGeAlD
Aminosalicylic Acid—PTGS1—forebrain—Parkinson's disease	0.00233	0.0249	CbGeAlD
Aminosalicylic Acid—PTGS2—forebrain—Parkinson's disease	0.00223	0.0238	CbGeAlD
Aminosalicylic Acid—MPO—brain—Parkinson's disease	0.00204	0.0218	CbGeAlD
Aminosalicylic Acid—L-DOPA—DRD2—Parkinson's disease	0.002	0.0357	CrCbGaD
Aminosalicylic Acid—PTGS1—cardiovascular system—Parkinson's disease	0.00197	0.021	CbGeAlD
Aminosalicylic Acid—PTGS2—cardiovascular system—Parkinson's disease	0.00188	0.0201	CbGeAlD
Aminosalicylic Acid—PTGS2—medulla oblongata—Parkinson's disease	0.00161	0.0172	CbGeAlD
Aminosalicylic Acid—PTGS1—spinal cord—Parkinson's disease	0.0015	0.016	CbGeAlD
Aminosalicylic Acid—PTGS2—midbrain—Parkinson's disease	0.00147	0.0157	CbGeAlD
Aminosalicylic Acid—PTGS2—spinal cord—Parkinson's disease	0.00144	0.0153	CbGeAlD
Aminosalicylic Acid—L-DOPA—CYP2D6—Parkinson's disease	0.00141	0.0252	CrCbGaD
Aminosalicylic Acid—PTGS1—head—Parkinson's disease	0.00134	0.0142	CbGeAlD
Aminosalicylic Acid—PTGS2—head—Parkinson's disease	0.00128	0.0136	CbGeAlD
Aminosalicylic Acid—PTGS1—nervous system—Parkinson's disease	0.00127	0.0135	CbGeAlD
Aminosalicylic Acid—PTGS1—central nervous system—Parkinson's disease	0.00122	0.013	CbGeAlD
Aminosalicylic Acid—PTGS2—nervous system—Parkinson's disease	0.00121	0.0129	CbGeAlD
Aminosalicylic Acid—PTGS2—central nervous system—Parkinson's disease	0.00116	0.0124	CbGeAlD
Aminosalicylic Acid—PTGS2—cerebellum—Parkinson's disease	0.00114	0.0121	CbGeAlD
Aminosalicylic Acid—Salicylic acid—ABCB1—Parkinson's disease	0.00112	0.0201	CrCbGaD
Aminosalicylic Acid—PTGS1—brain—Parkinson's disease	0.000967	0.0103	CbGeAlD
Aminosalicylic Acid—PTGS2—brain—Parkinson's disease	0.000925	0.00986	CbGeAlD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-DRA—Parkinson's disease	0.000733	0.000862	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—GPX1—Parkinson's disease	0.00073	0.000858	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000725	0.000853	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—INS—Parkinson's disease	0.000722	0.000849	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—DDC—Parkinson's disease	0.000689	0.00081	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HGF—Parkinson's disease	0.000687	0.000808	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TNF—Parkinson's disease	0.000685	0.000806	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—TNF—Parkinson's disease	0.000685	0.000806	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—FGF20—Parkinson's disease	0.000684	0.000804	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Activated TLR4 signalling—MAPK8—Parkinson's disease	0.000683	0.000803	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—IL1B—Parkinson's disease	0.000679	0.000798	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—MTHFR—Parkinson's disease	0.000673	0.000792	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PARK2—Parkinson's disease	0.000662	0.000779	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.000657	0.000773	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—FGF20—Parkinson's disease	0.000657	0.000772	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—FBP1—Parkinson's disease	0.000651	0.000766	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TAF1—Parkinson's disease	0.000651	0.000766	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GSTA4—Parkinson's disease	0.00065	0.000765	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VPS35—Parkinson's disease	0.000647	0.000761	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 4 (TLR4) Cascade—MAPK8—Parkinson's disease	0.000642	0.000755	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000642	0.000755	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—TNF—Parkinson's disease	0.000637	0.000749	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—IL1B—Parkinson's disease	0.000631	0.000742	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—NGF—Parkinson's disease	0.000628	0.000739	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—APOE—Parkinson's disease	0.000627	0.000737	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Parkinson's disease	0.000615	0.000723	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—CASP3—Parkinson's disease	0.000612	0.00072	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—Parkinson's disease	0.000605	0.000712	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—CASP3—Parkinson's disease	0.000589	0.000693	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.000588	0.000691	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—TNF—Parkinson's disease	0.000587	0.00069	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PLA2G6—Parkinson's disease	0.000586	0.000689	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—MAOB—Parkinson's disease	0.00058	0.000682	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.000579	0.000681	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—MAPK8—Parkinson's disease	0.000579	0.000681	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-Like Receptors Cascades—MAPK8—Parkinson's disease	0.000572	0.000673	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.00057	0.00067	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—Parkinson's disease	0.000569	0.00067	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—MAPK8—Parkinson's disease	0.000563	0.000662	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000552	0.000649	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88 cascade initiated on plasma membrane—IL6—Parkinson's disease	0.000548	0.000644	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—VPS35—Parkinson's disease	0.000547	0.000644	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—Parkinson's disease	0.000543	0.000638	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—IL1B—Parkinson's disease	0.000539	0.000634	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ND3—Parkinson's disease	0.000537	0.000631	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—MCCC1—Parkinson's disease	0.000537	0.000631	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—DGKQ—Parkinson's disease	0.000536	0.000631	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GPR37—Parkinson's disease	0.000536	0.000631	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—INS—Parkinson's disease	0.000536	0.00063	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88 dependent cascade initiated on endosome—IL6—Parkinson's disease	0.000533	0.000626	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—IL6—Parkinson's disease	0.000523	0.000615	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—RPL6—Parkinson's disease	0.00052	0.000612	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SNCA—Parkinson's disease	0.00052	0.000612	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 9 (TLR9) Cascade—IL6—Parkinson's disease	0.000514	0.000605	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—IL6—Parkinson's disease	0.000514	0.000605	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.000514	0.000604	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MCCC1—Parkinson's disease	0.000509	0.000598	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88:Mal cascade initiated on plasma membrane—IL6—Parkinson's disease	0.000505	0.000594	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—TALDO1—Parkinson's disease	0.000505	0.000594	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—OMD—Parkinson's disease	0.000505	0.000594	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—ADRBK1—Parkinson's disease	0.000503	0.000591	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—TNF—Parkinson's disease	0.000493	0.000579	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00049	0.000577	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—DCTN1—Parkinson's disease	0.000489	0.000575	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.000488	0.000574	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88-independent cascade—IL6—Parkinson's disease	0.000485	0.00057	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NDUFB11—Parkinson's disease	0.000478	0.000563	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TALDO1—Parkinson's disease	0.000478	0.000563	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—OMD—Parkinson's disease	0.000478	0.000563	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—MAPK8—Parkinson's disease	0.000477	0.000561	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—IL6—Parkinson's disease	0.000473	0.000557	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—TNF—Parkinson's disease	0.000458	0.000538	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GCH1—Parkinson's disease	0.000456	0.000537	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000453	0.000532	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—IL6—Parkinson's disease	0.000452	0.000532	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000449	0.000528	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-DRA—Parkinson's disease	0.000445	0.000523	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PLA2G6—Parkinson's disease	0.00044	0.000517	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Activated TLR4 signalling—IL6—Parkinson's disease	0.000436	0.000513	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CYP2D6—Parkinson's disease	0.000431	0.000507	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RIT2—Parkinson's disease	0.000429	0.000504	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL1B—Parkinson's disease	0.000426	0.000501	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ND3—Parkinson's disease	0.000426	0.000501	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—MCCC1—Parkinson's disease	0.000426	0.000501	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—CASP3—Parkinson's disease	0.000425	0.0005	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CTGF—Parkinson's disease	0.000423	0.000497	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000412	0.000484	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 4 (TLR4) Cascade—IL6—Parkinson's disease	0.00041	0.000482	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—ABL1—Parkinson's disease	0.00041	0.000482	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GBA—Parkinson's disease	0.000407	0.000478	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—FBP1—Parkinson's disease	0.000407	0.000478	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—DBH—Parkinson's disease	0.000407	0.000478	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GRK5—Parkinson's disease	0.000406	0.000478	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PARK2—Parkinson's disease	0.000402	0.000472	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—TALDO1—Parkinson's disease	0.000401	0.000471	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—OMD—Parkinson's disease	0.000401	0.000471	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FGF20—Parkinson's disease	0.000398	0.000469	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—IL6—Parkinson's disease	0.000397	0.000467	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—RPL23A—Parkinson's disease	0.000394	0.000464	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—RPL14—Parkinson's disease	0.000394	0.000464	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CYP2E1—Parkinson's disease	0.000394	0.000463	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—TNF—Parkinson's disease	0.000391	0.00046	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—NQO1—Parkinson's disease	0.00039	0.000458	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TAF1—Parkinson's disease	0.000386	0.000453	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FBP1—Parkinson's disease	0.000386	0.000453	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—TH—Parkinson's disease	0.000384	0.000452	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NDUFB11—Parkinson's disease	0.00038	0.000447	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—IL6—Parkinson's disease	0.00037	0.000435	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CYCS—Parkinson's disease	0.000369	0.000434	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—FGF20—Parkinson's disease	0.000368	0.000433	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—RPS8—Parkinson's disease	0.000368	0.000433	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-Like Receptors Cascades—IL6—Parkinson's disease	0.000365	0.00043	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—IL6—Parkinson's disease	0.000365	0.00043	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GRM4—Parkinson's disease	0.000364	0.000429	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GCH1—Parkinson's disease	0.000362	0.000426	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL1B—Parkinson's disease	0.00036	0.000424	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.000355	0.000418	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—CASP3—Parkinson's disease	0.000354	0.000416	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—IL6—Parkinson's disease	0.00035	0.000411	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PENK—Parkinson's disease	0.000345	0.000406	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MAG—Parkinson's disease	0.000345	0.000406	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—IL6—Parkinson's disease	0.000344	0.000405	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—IL6—Parkinson's disease	0.000329	0.000386	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—IL6—Parkinson's disease	0.000327	0.000384	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000327	0.000384	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—COMT—Parkinson's disease	0.000326	0.000384	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—IL6—Parkinson's disease	0.000325	0.000383	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GSTP1—Parkinson's disease	0.000325	0.000382	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—MAPK8—Parkinson's disease	0.000325	0.000382	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—MAOA—Parkinson's disease	0.000324	0.000381	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—IL6—Parkinson's disease	0.000324	0.000381	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—DBH—Parkinson's disease	0.000323	0.00038	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GBA—Parkinson's disease	0.000323	0.00038	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—FBP1—Parkinson's disease	0.000323	0.00038	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—HMOX1—Parkinson's disease	0.00032	0.000377	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PDYN—Parkinson's disease	0.000316	0.000372	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—IL6—Parkinson's disease	0.000316	0.000371	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TNF—Parkinson's disease	0.000309	0.000364	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—RPL6—Parkinson's disease	0.000308	0.000363	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SNCA—Parkinson's disease	0.000308	0.000363	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—ABCB1—Parkinson's disease	0.000308	0.000362	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—IL6—Parkinson's disease	0.000305	0.000358	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—Parkinson's disease	0.000305	0.000358	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—IL6—Parkinson's disease	0.000305	0.000358	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—IL6—Parkinson's disease	0.000302	0.000355	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—IL6—Parkinson's disease	0.000299	0.000352	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GSTM1—Parkinson's disease	0.000299	0.000351	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—DDC—Parkinson's disease	0.000299	0.000351	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—IL6—Parkinson's disease	0.000298	0.00035	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GFAP—Parkinson's disease	0.000297	0.000349	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GRM5—Parkinson's disease	0.000294	0.000345	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ADRBK1—Parkinson's disease	0.000293	0.000344	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.000289	0.00034	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GPX1—Parkinson's disease	0.000286	0.000336	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GSTA4—Parkinson's disease	0.000282	0.000332	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000278	0.000327	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—ADRBK1—Parkinson's disease	0.00027	0.000318	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—Parkinson's disease	0.00027	0.000317	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HSPA1A—Parkinson's disease	0.000268	0.000316	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000266	0.000313	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—MTHFR—Parkinson's disease	0.000264	0.00031	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGF20—Parkinson's disease	0.000258	0.000303	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PLA2G6—Parkinson's disease	0.000254	0.000299	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—MAOB—Parkinson's disease	0.000251	0.000296	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ADORA2A—Parkinson's disease	0.00025	0.000294	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL6—Parkinson's disease	0.00025	0.000293	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—APOE—Parkinson's disease	0.000246	0.000289	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000239	0.000281	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ABL1—Parkinson's disease	0.000239	0.000281	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—DDC—Parkinson's disease	0.000237	0.000279	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—RPL23A—Parkinson's disease	0.000234	0.000275	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—RPL14—Parkinson's disease	0.000234	0.000275	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—INSR—Parkinson's disease	0.000231	0.000271	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HGF—Parkinson's disease	0.000224	0.000264	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GSTA4—Parkinson's disease	0.000224	0.000263	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000221	0.00026	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—RPS8—Parkinson's disease	0.000218	0.000256	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGF20—Parkinson's disease	0.000218	0.000256	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGB—Parkinson's disease	0.000218	0.000256	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HTR1A—Parkinson's disease	0.000217	0.000255	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TAC1—Parkinson's disease	0.000213	0.000251	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL6—Parkinson's disease	0.000211	0.000248	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.00021	0.000247	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—INS—Parkinson's disease	0.00021	0.000247	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—DRD1—Parkinson's disease	0.000209	0.000246	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—IL6—Parkinson's disease	0.000207	0.000244	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—DRD3—Parkinson's disease	0.000203	0.000238	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PLA2G6—Parkinson's disease	0.000202	0.000237	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—MAOB—Parkinson's disease	0.0002	0.000235	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.00019	0.000223	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ADRBK1—Parkinson's disease	0.000189	0.000223	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP2D6—Parkinson's disease	0.000187	0.00022	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—MAPK8—Parkinson's disease	0.000185	0.000218	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CTGF—Parkinson's disease	0.000183	0.000216	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—DRD2—Parkinson's disease	0.000183	0.000216	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HTR7—Parkinson's disease	0.000183	0.000216	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MTHFR—Parkinson's disease	0.000183	0.000215	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP2E1—Parkinson's disease	0.000171	0.000201	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APOE—Parkinson's disease	0.00017	0.0002	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NQO1—Parkinson's disease	0.000169	0.000199	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—TH—Parkinson's disease	0.000166	0.000196	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ADRBK1—Parkinson's disease	0.00016	0.000188	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYCS—Parkinson's disease	0.00016	0.000188	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HSPA1A—Parkinson's disease	0.000159	0.000187	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IGF2—Parkinson's disease	0.000154	0.000181	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IGF1R—Parkinson's disease	0.000149	0.000175	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP2D6—Parkinson's disease	0.000148	0.000174	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EDN1—Parkinson's disease	0.000147	0.000173	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—INS—Parkinson's disease	0.000146	0.000171	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CTGF—Parkinson's disease	0.000146	0.000171	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—COMT—Parkinson's disease	0.000142	0.000166	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GSTP1—Parkinson's disease	0.000141	0.000166	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—MAOA—Parkinson's disease	0.000141	0.000165	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—HMOX1—Parkinson's disease	0.000139	0.000163	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP2E1—Parkinson's disease	0.000136	0.000159	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NGF—Parkinson's disease	0.000135	0.000159	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NQO1—Parkinson's disease	0.000134	0.000158	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ABCB1—Parkinson's disease	0.000133	0.000157	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—TH—Parkinson's disease	0.000132	0.000155	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GSTM1—Parkinson's disease	0.000129	0.000152	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HTR2A—Parkinson's disease	0.000128	0.000151	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYCS—Parkinson's disease	0.000127	0.000149	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GPX1—Parkinson's disease	0.000124	0.000146	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APOE—Parkinson's disease	0.000119	0.00014	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IL6—Parkinson's disease	0.000118	0.000139	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL1B—Parkinson's disease	0.000118	0.000138	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—MTHFR—Parkinson's disease	0.000114	0.000135	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—COMT—Parkinson's disease	0.000112	0.000132	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GSTP1—Parkinson's disease	0.000112	0.000132	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—MAOA—Parkinson's disease	0.000112	0.000131	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—HMOX1—Parkinson's disease	0.00011	0.00013	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MTHFR—Parkinson's disease	0.000108	0.000128	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MAPK8—Parkinson's disease	0.000108	0.000127	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—APOE—Parkinson's disease	0.000107	0.000125	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ABCB1—Parkinson's disease	0.000106	0.000125	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GSTM1—Parkinson's disease	0.000103	0.000121	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—INS—Parkinson's disease	0.000102	0.00012	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APOE—Parkinson's disease	0.000101	0.000119	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GPX1—Parkinson's disease	9.84e-05	0.000116	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—INS—Parkinson's disease	9.1e-05	0.000107	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—MTHFR—Parkinson's disease	9.08e-05	0.000107	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—INS—Parkinson's disease	8.63e-05	0.000101	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOE—Parkinson's disease	8.46e-05	9.94e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CASP3—Parkinson's disease	7.59e-05	8.93e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—INS—Parkinson's disease	7.22e-05	8.5e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MAPK8—Parkinson's disease	6.98e-05	8.21e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL6—Parkinson's disease	6.89e-05	8.11e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IL6—Parkinson's disease	6.36e-05	7.48e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL6—Parkinson's disease	4.46e-05	5.24e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IL6—Parkinson's disease	3.77e-05	4.43e-05	CbGpPWpGaD
